Cargando…
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
The CRISPR/Cas9 systems have revolutionized the field of genome editing by providing unprecedented control over gene sequences and gene expression in many species, including humans. Lentiviral vectors (LVs) are one of the primary delivery platforms for the CRISPR/Cas9 system due to their ability to...
Autores principales: | Ortinski, Pavel I., O’Donovan, Bernadette, Dong, Xiaoyu, Kantor, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424571/ https://www.ncbi.nlm.nih.gov/pubmed/28497073 http://dx.doi.org/10.1016/j.omtm.2017.04.002 |
Ejemplares similares
-
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
por: Dong, Wendy, et al.
Publicado: (2021) -
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021) -
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018) -
Integrase deficient lentiviral vector: prospects for safe clinical applications
por: Yew, Chee-Hong Takahiro, et al.
Publicado: (2022) -
Use of Integrase-Minus Lentiviral Vector for Transient
Expression
por: Farazmandfar, Touraj, et al.
Publicado: (2012)